Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

NCT03600766 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03600766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03600766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study
Lead sponsor
Mansoura University
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2018
Completion date
January 1, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph, erectile abnormalities, erectile dysfunction, prostate hyperplasia, prostatic neoplasms